Choose Konosai for domestic substitution

MORE

Oligonucleotide drugs
Purification solution

MORE

Ultra large pore chromatography separation
Technology leaders

MORE

Scale up of chromatographic media
Production and manufacturing enterprises

MORE

Focusing on downstream biopharmaceutical industry
Provide separation and purification solutions

MORE

Products And Services

MORE

Application Center

Vaccines&Viruses

Vaccines, the shield to protect health; Viruses challenge the enemy of life. Vaccinate and build a great wall of epidemic prevention together.

MORE >

Cell&Gene Therapy

Cell gene therapy, innovative medical technology, reshaping life and health, opening a new chapter in healing.

MORE >

Small Nucleic Acid Drugs

Small nucleic acid drugs can precisely regulate gene expression, usher in a new era of disease treatment, and reshape a new future of life and health.

MORE >

Insulin&Peptides

Insulin and peptides work together to regulate life activities, promote health, and create a new chapter in medicine.

MORE >

Blood Products

Blood products protect the source of life, ensure health and safety, and contribute to the medical industry.

MORE >

Recombinant Protein

Recombinant proteins, technology leading innovation, supporting biomedical applications, and safeguarding human health.

MORE >

Antibody Drugs

Antibody drugs, precise targeting, efficient treatment, safeguard health, and usher in a new era of medical care.

MORE >

Insulin&Peptides

Cell&Gene Therapy

Small Nucleic Acid Drugs

Insulin&Peptides

Blood Products

Recombinant Protein

Antibody Drugs

Get Free Solutions

Konosai specializes in providing comprehensive solutions for the separation and purification of biomolecules for biopharmaceutical enterprises, CDMO companies, CRO companies, and research institutions.

Hotline 0532-55679191

About Us

A high-tech enterprise with chromatography purification products as its core

Konosai is a high-tech enterprise with chromatography purification products as its core, focusing on providing separation and purification solutions for downstream biopharmaceutical industries. With continuous research and development innovation and profound technological accumulation, Konosai has successfully built two major research and development technology platforms for polymers and agarose, and developed four categories of chromatography fillers: polystyrene/divinylbenzene matrix (PS-DVB), polymethyl methacrylate matrix (PMMA), agarose matrix, and glucan matrix. At the same time, it provides a variety of chromatography columns and oligonucleotide solid-phase synthesis carriers, covering different stages and application scenarios of downstream purification, and its product performance can benchmark against internationally renowned brands.

Learn More

News

MORE

Research and development, production, and global sales

Customer centricity and market orientation

Konosai is customer-centric and market-oriented, focusing on product research and development, technological innovation, and process development. It currently has three major institutions: application centers (Beijing, Qingdao), research and development and pilot centers (Qingdao). At the same time, it will gradually expand its industrial chain layout, provide comprehensive services to biopharmaceutical enterprises, and contribute to the localization of key raw materials for biopharmaceuticals.

Konosai Biotechnology Co., Ltd

TEL:0532-55679191

E-mail:marketing@chromsep.cn

R&D Center:Building A3, 6th Floor, Blue Bay Entrepreneurship Park, No.1 Jinhui Road, High tech Zone, Qingdao City, Shandong Province

  • WeChat Official

  • Website Mobile

Copyright © 2023-2024 科诺赛生物科技有限公司 版权所有 Record number:鲁ICP备2022000479号

Technical support: WDL